Foegh ML et al. |
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. |
1986 |
Transplantation |
pmid:3523888
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Gilli UO et al. |
Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. |
2005 |
Transplantation |
pmid:15912099
|
Freiche JC et al. |
Prolonged survival of renal transplants in nonimmunized and hyperimmunized rats receiving a platelet-activating factor antagonist. |
1990 |
Transplantation |
pmid:2368154
|
Lanese DM et al. |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. |
1994 |
Transplantation |
pmid:7809931
|
Makowka L et al. |
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. |
1990 |
Transplantation |
pmid:2402783
|
Biancone L et al. |
Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. |
2006 |
Transplantation |
pmid:16495796
|
Saumweber DM et al. |
Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS. |
1994 |
Transplantation |
pmid:8108870
|
Camussi G et al. |
Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. |
1987 |
Transplantation |
pmid:3299910
|
Kawahara K et al. |
The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung. |
1993 |
Transplantation |
pmid:8516834
|
Conte JV et al. |
Long-term lung preservation with the PAF antagonist BN 52021. |
1991 |
Transplantation |
pmid:2048190
|
Marathe GK et al. |
Oxidized LDL contains inflammatory PAF-like phospholipids. |
2001 Apr-May |
Trends Cardiovasc. Med. |
pmid:11686003
|
Zimmerman GA and McIntyre TM |
PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. |
2004 |
Trends Mol Med |
pmid:15177186
|
Braquet P et al. |
Is there a case for PAF antagonists in the treatment of ischemic states? |
1989 |
Trends Pharmacol. Sci. |
pmid:2688213
|
Izzo AA et al. |
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. |
1998 |
Trends Pharmacol. Sci. |
pmid:9803830
|
Page C and Abbott A |
PAF: new antagonists, new roles in disease and a major role in reproductive biology. |
1989 |
Trends Pharmacol. Sci. |
pmid:2672467
|
GarcÃa-Sáinz JA |
Intercellular communication within the liver has clinical implications. |
1989 |
Trends Pharmacol. Sci. |
pmid:2595791
|
O'Neill C |
A physiological role for PAF in the stimulation of mammalian embryonic development. |
1991 |
Trends Pharmacol. Sci. |
pmid:2053190
|
GamaleÄ IA et al. |
[Post-receptor formation of active forms of oxygen in nonphagocytic cells]. |
1999 |
Tsitologiia |
pmid:10496012
|
Harputluoglu MM et al. |
The effects of Gingko biloba extract on acetic acid-induced colitis in rats. |
2006 |
Turk J Gastroenterol |
pmid:16941250
|
Kabasakal C et al. |
The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. |
1998 Jul-Sep |
Turk. J. Pediatr. |
pmid:9763906
|
Hansen JF and Hansen BF |
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. |
1987 |
Ugeskr. Laeg. |
pmid:3324429
|
Vavilova GL et al. |
[The role of the thrombocyte-activating factor in inhibiting Na+,K(+)-ATPase in different tissues after ischemia and reperfusion of the small intestine]. |
1996 Mar-Apr |
Ukr. Biokhim. Zh. |
pmid:9005660
|
Yildirim G et al. |
Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. |
2000 |
Undersea Hyperb Med |
pmid:11191161
|
Mehta A and Sigman M |
Identification and preparation of sperm for ART. |
2014 |
Urol. Clin. North Am. |
pmid:24286775
|
Imagawa M et al. |
Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma. |
1996 |
Urol. Int. |
pmid:8840484
|
Rastogi P et al. |
Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. |
2011 |
Urology |
pmid:21094990
|
Baka S et al. |
Treatment of sperm with platelet-activating factor does not improve intrauterine insemination outcome in unselected cases of mild male factor infertility: a prospective double-blind randomized crossover study. |
2009 |
Urology |
pmid:19716589
|
Kim YH et al. |
SIRT1 attenuates PAF-induced MMP-2 production via down-regulation of PAF receptor expression in vascular smooth muscle cells. |
2015 |
Vascul. Pharmacol. |
pmid:25967595
|
Marathe GK et al. |
Activation of vascular cells by PAF-like lipids in oxidized LDL. |
2002 |
Vascul. Pharmacol. |
pmid:12449015
|
Hemker HC and Béguin S |
The generation of thrombin in whole plasma. Biochemical possibilities and physiological realities. |
1985 |
Verh. K. Acad. Geneeskd. Belg. |
pmid:4090648
|
Kulikov VI and Muzia GI |
[Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine]. |
1991 |
Vestn. Akad. Med. Nauk SSSR |
pmid:1801455
|
Fedorov NA |
[Physiological variants of functional and biochemical indicators of thrombocytes]. |
1991 |
Vestn. Akad. Med. Nauk SSSR |
pmid:1801458
|
Kaminskaia GO and Aladysheva ZhI |
[Platelet activating factor and pulmonary tuberculosis]. |
1995 |
Vestn. Akad. Med. Nauk SSSR |
pmid:7670343
|
Strukova SM et al. |
[Regulation of thrombocyte stimulating and other activities of thrombin by modulators of the recognition site]. |
1991 |
Vestn. Akad. Med. Nauk SSSR |
pmid:1724858
|
Shabanov VV |
[Cytokines and other signal molecules in the pathogenesis of acute pancreatitis]. |
2003 |
Vestn. Akad. Med. Nauk SSSR |
pmid:14598737
|
Moore RM et al. |
Effect of platelet-activating factor antagonist L-691,880 on low-flow ischemia-reperfusion injury of the large colon in horses. |
1998 Jan-Feb |
Vet Surg |
pmid:9449176
|
Leid RW and Potter KA |
Inflammation and mediators of lung injury. |
1985 |
Vet. Clin. North Am. Food Anim. Pract. |
pmid:3907779
|
Alarcón P et al. |
D-lactic acid interferes with the effects of platelet activating factor on bovine neutrophils. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21816488
|
Carretta MD et al. |
Butyric acid stimulates bovine neutrophil functions and potentiates the effect of platelet activating factor. |
2016 |
Vet. Immunol. Immunopathol. |
pmid:27288853
|
Waller KP |
Modulation of endotoxin-induced inflammation in the bovine teat using antagonists/inhibitors to leukotrienes, platelet activating factor and interleukin 1 beta. |
1997 |
Vet. Immunol. Immunopathol. |
pmid:9261962
|
Conejeros I et al. |
2-Aminoethoxydiphenyl borate (2-APB) reduces alkaline phosphatase release, CD63 expression, F-actin polymerization and chemotaxis without affecting the phagocytosis activity in bovine neutrophils. |
2012 |
Vet. Immunol. Immunopathol. |
pmid:22226550
|
Cook VL et al. |
The effect of lidocaine on in vitro adhesion and migration of equine neutrophils. |
2009 |
Vet. Immunol. Immunopathol. |
pmid:19136156
|
Aktan I et al. |
PKC isoenzymes in equine platelets and stimulus induced activation. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21513989
|
Topper EK et al. |
Induction of tissue eosinophilia by platelet-activating factor in Merino sheep. |
1992 |
Vet. Immunol. Immunopathol. |
pmid:1604802
|
Foster AP et al. |
Platelet activating factor mimics antigen-induced cutaneous inflammatory responses in sweet itch horses. |
1995 |
Vet. Immunol. Immunopathol. |
pmid:7747395
|
Brooks AC et al. |
CXCL8 attenuates chemoattractant-induced equine neutrophil migration. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21040981
|
Corl CM et al. |
Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. |
2010 |
Vet. Immunol. Immunopathol. |
pmid:20359754
|
Strøm H and Thomsen MK |
Effects of proinflammatory mediators on canine neutrophil chemotaxis and aggregation. |
1990 |
Vet. Immunol. Immunopathol. |
pmid:2396362
|
Larrazabal CS et al. |
Amiloride interferes with platelet- activating factor-induced respiratory burst and MMP-9 release in bovine neutrophils independent of Na/H exchanger 1. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28895869
|
Marr KA et al. |
Agonist-induced adherence of equine neutrophils to fibronectin- and serum-coated plastic is CD18 dependent. |
1999 |
Vet. Immunol. Immunopathol. |
pmid:10532398
|
Van de Weerdt ML et al. |
Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. |
1999 |
Vet. J. |
pmid:10030127
|
Michelotto PV et al. |
Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. |
2011 |
Vet. J. |
pmid:22108190
|
da Silva MB et al. |
Effect of ketoprofen on PAF-induced bovine platelet aggregation. |
1998 |
Vet. J. |
pmid:9564275
|
Slauson DO and Sanchez-Vizcaino JM |
Leukocyte-dependent platelet vasoactive amine release and immune complex deposition in African swine fever. |
1981 |
Vet. Pathol. |
pmid:6170156
|
Wimberly HC et al. |
Functional and biochemical characterization of immunologically derived equine platelet-activating factor. |
1985 |
Vet. Pathol. |
pmid:4035942
|
Van de Weerdt ML et al. |
Effect of platelet-activating factor on bovine pulmonary function. |
1997 |
Vet. Rec. |
pmid:9290195
|
Bastos da Silva M et al. |
Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves. |
1997 Sep-Oct |
Vet. Res. |
pmid:9342825
|
Lallès JP et al. |
Small intestinal motility disorders in preruminant calves chronically fed a diet based on antigenic soya: characterization and possible mediators. |
1998 Jan-Feb |
Vet. Res. |
pmid:9559521
|
Bastos da Silva M et al. |
In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. |
2000 Mar-Apr |
Vet. Res. |
pmid:10779205
|
Diez-Fraile A et al. |
Analysis of selective mobilization of L-selectin and Mac-1 reservoirs in bovine neutrophils and eosinophils. |
2003 Jan-Feb |
Vet. Res. |
pmid:12588684
|
Bastos da Silva MB et al. |
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves. |
1997 |
Vet. Res. Commun. |
pmid:9345719
|
da Silva MB et al. |
Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. |
1998 |
Vet. Res. Commun. |
pmid:9686442
|
Dawson J et al. |
Platelet activating factor as a mediator of equine cell locomotion. |
1988 |
Vet. Res. Commun. |
pmid:3188378
|
Venugopalan CS et al. |
Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. |
1998 |
Vet. Res. Commun. |
pmid:9868763
|
DaÄkhin EI et al. |
[Clinical significance of studies of platelet activating factor (review of the literature)]. |
1989 Mar-Apr |
Vopr. Med. Khim. |
pmid:2662595
|
Shebzukhov IuV and Mysiakin EB |
[Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system]. |
1996 Oct-Dec |
Vopr. Med. Khim. |
pmid:9254510
|
Muzia GI et al. |
[Inhibition of formation of superoxide radicals in leukocytes of hypercholesteremic patients under the effect of a lipid platelet activation factor antagonist]. |
1995 Jul-Aug |
Vopr. Med. Khim. |
pmid:8571587
|
Denizot Y and Nathan N |
Platelet-activating factor in operative salvaged blood. |
1994 |
Vox Sang. |
pmid:7801619
|
Silliman CC et al. |
Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. |
1992 |
Vox Sang. |
pmid:1332255
|
Sieunarine K et al. |
Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood. |
1992 |
Vox Sang. |
pmid:1333134
|
Robeva R et al. |
[Changes in blood coagulation in glomerulonephritis]. |
1982 |
Vutr Boles |
pmid:6219496
|
Guan Z et al. |
[Role of interleukin-6 and platelet-activating factor in delaying neutrophil apoptosis]. |
2000 |
Wei Sheng Yan Jiu |
pmid:12725051
|
Chmiel B |
[The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro]. |
2002 |
Wiad. Lek. |
pmid:12715347
|
Keck M et al. |
Pathophysiology of burns. |
2009 |
Wien Med Wochenschr |
pmid:19652939
|
Czarnetzki BM |
[Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. |
1987 |
Wien Med Wochenschr Suppl |
pmid:3078398
|
Connolly AB and Vernon DR |
Manipulations of the metabolic response for management of patients with severe surgical illness: review. |
2000 |
World J Surg |
pmid:10773122
|
Bang UC et al. |
Pharmacological approach to acute pancreatitis. |
2008 |
World J. Gastroenterol. |
pmid:18494044
|
Xia SH et al. |
Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. |
2007 |
World J. Gastroenterol. |
pmid:17589953
|
Xia SH et al. |
Roles of BN52021 in platelet-activating factor pathway in inflammatory MS1 cells. |
2013 |
World J. Gastroenterol. |
pmid:23840141
|
Chen Y et al. |
Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertension. |
2008 |
World J. Gastroenterol. |
pmid:18186558
|
Lu YY et al. |
Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. |
2008 |
World J. Gastroenterol. |
pmid:18205269
|
Cao HC et al. |
Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. |
2005 |
World J. Gastroenterol. |
pmid:16437644
|
Bock J et al. |
Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. |
2007 |
World J. Gastroenterol. |
pmid:17876892
|
Liu LR and Xia SH |
Role of platelet-activating factor in the pathogenesis of acute pancreatitis. |
2006 |
World J. Gastroenterol. |
pmid:16489665
|
Zhou ZG and Chen YD |
Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. |
2002 |
World J. Gastroenterol. |
pmid:12046059
|
Torres MI and Rios A |
Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. |
2008 |
World J. Gastroenterol. |
pmid:18395894
|
Yang YP et al. |
Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis. |
2006 |
World J. Gastroenterol. |
pmid:16521183
|
Mathonnet M et al. |
Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. |
2006 |
World J. Gastroenterol. |
pmid:16718768
|
Karidis NP et al. |
Platelet-activating factor in liver injury: a relational scope. |
2006 |
World J. Gastroenterol. |
pmid:16773686
|
Zhao H et al. |
Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis. |
2003 |
World J. Gastroenterol. |
pmid:12532462
|
Sperling RI |
Effects of dietary fish oil on leukocyte leukotriene and PAF generation and on neutrophil chemotaxis. |
1991 |
World Rev Nutr Diet |
pmid:2053354
|
Tanaka E et al. |
Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog. |
1994 |
Xenobiotica |
pmid:8059533
|
Nunoya K et al. |
S-oxidation of (+)-cis-3,5-dimethyl-2-(3-pyridyl)-thiazolidin-4-one hydrochloride by rat hepatic flavin-containing monooxygenase 1 expressed in yeast. |
1995 |
Xenobiotica |
pmid:8719904
|
Thomson KL et al. |
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys. |
1991 |
Xenobiotica |
pmid:1949894
|
Kobayashi T et al. |
Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs. |
1988 |
Xenobiotica |
pmid:3354232
|
Kusano K et al. |
Pharmacokinetics of a new thienodiazepine platelet activating factor receptor antagonist (E6123) in laboratory animals. Is there a metabolic polymorphism in the rhesus monkey? |
1993 |
Xenobiotica |
pmid:8212733
|
Kusano K et al. |
Metabolic polymorphism of E6123 in rhesus monkey. |
1993 |
Xenobiotica |
pmid:8212734
|
Kase N et al. |
[Pharmacological profile of F-0401, a novel dihydropyridine derivative. III. The anti-aggregatory action of F-0401 on rabbit platelets]. |
1995 |
Yakugaku Zasshi |
pmid:7699581
|
Ohishi S |
[Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. |
2000 |
Yakugaku Zasshi |
pmid:10825809
|